Zusammenfassung
Die Mehrzahl aller Kopfschmerzpatienten leidet unter primären Zephalgien, ganz überwiegend unter Migräne und Spannungskopfschmerz. Zu dieser Gruppe zählen weitere sehr seltene Formen, die erst 2004 in der zweiten, revidierten Kopfschmerzklassifikation der International Headache Society (IHS) angeführt wurden. Ihre typische klinische Symptomatik ist weniger bekannt. Die Diagnose dieser Kopfschmerzsyndrome ist aber wichtig, weil sie meistens einer effektiven spezifischen Therapie zugeführt werden können. Die vorliegende Übersicht fasst den aktuellen Wissensstand über Klinik und Behandlungsmöglichkeiten von Cluster-Kopfschmerz, paroxysmaler Hemikranie, SUNCT-Syndrom, Hemicrania continua und Hypnic headache zusammen.
Summary
Tension-type headache and migraine are the most common types of primary headaches. Apart from these well known diseases, the group of primary headaches includes other relatively rare headache disorders. Some of these seldom syndromes have been described for the first time within the last twenty years and have been newly included in the revised IHS classification from 2004.
Their typical symptomatic is less known, but offers an excellent opportunity to diagnose these syndromes. The importance of recognising these disorders is underlined by the fact, that rare primary headaches response often complete and rapid to a specific treatment. This review summarizes the current knowledge on the clinical presentation and treatment of cluster headache, paroxysmal hemicrania, SUNCT syndrome, hemicrania continua and hypnic headache.
Literatur
1
Antonaci F, Sjaastad O.
Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.
Headache.
1989;
29
648-656
2
Bahra A, May A, Goadsby P J.
Cluster headache: a prospective clinical study with diagnostic implications.
Neurology.
2002;
58
354-361
3
Bordini C, Antonaci F, Stovner L J, Schrader H, Sjaastad O.
„Hemicrania continua”: a clinical review.
Headache.
1991;
31
20-26
4
Busch V, May A.
Trigemino-autonomic headache syndromes.
Fortschr Neurol Psychiatr.
2003;
71
17-23
5
Bussone G, Leone M, Peccarisi C. et al .
Double blind comparison of lithium and verapamil in cluster headache prophylaxis.
Headache.
1990;
30
411-417
6
Couch J R, Ziegler D K.
Prednisone therapy for cluster headache.
Headache.
1978;
18
219-221
7
Dodick D W, Rozen T D, Goadsby P J, Silberstein S D.
Cluster headache.
Cephalalgia.
2000;
20
787-803
8
Dodick D W.
Indomethacin-responsive headache syndromes.
Curr Pain Headache Rep.
2004;
8
19-26
9
Ekbom K, Hardebo J E.
Cluster headache: aetiology, diagnosis and management.
Drugs.
2002;
62
61-69
10
Ekbom K, Krabbe A, Micieli G. et al .
Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group.
Cephalalgia.
1995;
15
230-236
11
Evans R W.
Diagnostic testing for the evaluation of headaches.
Neurol Clin.
1996;
14
1-26
12
Evers S, Goadsby P J.
Hypnic headache: clinical features, pathophysiology, and treatment.
Neurology.
2003;
60
905-909
13
Evers S, Husstedt I W.
Alternatives in drug treatment of chronic paroxysmal hemicrania.
Headache.
1996;
36
429-432
14 Evers S, Limmroth V, May A, Straube A. Cluster Kopfschmerzen. Stuttgart: Georg Thieme Verlag In: HC Diener für die Komission „Leitlinien” der Deutschen Gesellschaft für Neurologie (Hrsg.). Leitlinien für Diagnostik und Therapie in der Neurologie 2003: 322-324
15
Fogan L.
Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation.
Arch Neurol.
1985;
42
362-363
16
Ghiotto N, Sances G, Di Lorenzo G. et al .
Report of eight new cases of hypnic headache and mini-review of the literature.
Funct Neurol.
2002;
17
211-219
17
Goadsby P J, Lipton R B.
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.
Brain.
1997;
120
193-209
18
Gobel H, Lindner V, Heinze A, Ribbat M, Deuschl G.
Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study.
Neurology.
1998;
51
908-911
19
Göbel H, Petersen-Braun M, Soyka D.
The epidemiology of headache in Germany: a nationwide survey of representative sample on the basis of the headache classification of the International Headache Society.
Cephalalgia.
1994;
14
97-106
20
Headache Classification Subcommittee of the International Headache Society .
The International Classification of Headache Disorders: 2nd edition.
Cephalalgia.
2004;
24
(Suppl 1)
9-160
21
Kavuk I, Katsarava Z, Stang A, Agelink M W, Diener H C.
Neues zur Epidemiologie von Kopfschmerzen.
Fortschr Neurol Psychiatr.
2004;
72
184-191
22 Kuhn J, Bewermeyer H. Kopf- und Gesichtsschmerzen. 5. Auflage Stuttgart: Schattauer (in press) In: Conen, Griebenow, Meuthen, Schrappe, Steffen (Hrsg.): Internistische Differenzialdiagnostik. Klinische Pfade und Entscheidungsprozesse in Flussdiagrammen
23
Kuhn J, Kuhn K F, Cooper-Mahkorn D, Bewermeyer H.
Remitting form of Hemicrania continua: Two new cases exhibiting one unusual autonomic feature.
Headache.
2005;
in press
24
Kuhn J, Vosskaemper M, Bewermeyer H.
SUNCT syndrome: a possible bilateral case responding to topiramate.
Neurology.
2005;
in press
25
Lainez M J, Pascual J, Pascual A M, Santonja J M, Ponz A, Salvador A.
Topiramate in the prophylactic treatment of cluster headache.
Headache.
2003;
43
784-789
26
Leone M, D’Amico D, Frediani F. et al .
Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo.
Neurology.
2000;
54
1382-1385
27
Loder E W, Biondi D M.
Off-label prescribing of drugs in specialty headache practice.
Headache.
2004;
44
6366-6341
28
Markley H G.
Topical agents in the treatment of cluster headache.
Curr Pain Headache Rep.
2003;
7
139-143
29
Matharu M S, Cohen A S, Boes C J, Goadsby P J.
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review.
Curr Pain Headache Rep.
2003;
7
308-318
30
Matharu M S, Cohen A S, McGonigle D J, Ward N, Frackowiak R S, Goadsby P J.
Posterior hypothalamic and brainstem activation in hemicrania continua.
Headache.
2004;
44
747-761
31
Matharu M S, Goadsby P J.
Trigeminal autonomic cephalgias.
J Neurol Neurosurg Psychiatry.
2002;
72
(Suppl 2)
ii19-ii26
32
May A, Bahra A, Buchel C, Frackowiak R S, Goadsby P J.
Hypothalamic activation in cluster headache attacks.
Lancet.
1998;
352
275-278
33
May A, Bahra A, Buchel C, Turner R, Goadsby P J.
Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.
Ann Neurol.
1999;
46
791-794
34
May A, Evers S, Straube A, Pfaffenrath V, Diener H C.
Therapie und Prophylaxe von Cluster Kopfschmerzen und anderen Trigemino-Autonomen Kopfschmerzen. Überarbeitete Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft.
Nervenheilkunde.
2004;
23
478-490
35
May A.
The trigeminovascular system in the human. Cerebral blood flow, functional imaging and primary headache.
Nervenarzt.
2003;
74
1067-1077
36
McGeeney B E.
Topiramate in the treatment of cluster headache.
Curr Pain Headache Rep.
2003;
7
135-138
37
Newman L C, Lipton R B, Solomon S.
Hemicrania continua: ten new cases and a review of the literature.
Neurology.
1994;
44
2111-2114
38
Peres M F, Silberstein S D, Nahmias S. et al .
Hemicrania continua is not that rare.
Neurology.
2001;
57
948-951
39
Pinessi L, Rainero I, Cicolin A, Zibetti M, Gentile S, Mutani R.
Hypnic headache syndrome: association of the attacks with REM sleep.
Cephalalgia.
2003;
23
150-154
40
Raskin N H.
The hypnic headache syndrome.
Headache.
1988;
28
534-536
41
Robbins L.
Intranasal lidocaine for cluster headache.
Headache.
1995;
35
83-84
42
Rossi P, Cesarino F, Faroni J, Malpezzi M G, Sandrini G, Nappi G.
SUNCT syndrome successfully treated with topiramate: case reports.
Cephalalgia.
2003;
23
998-1000
43
Sibon I, Ghorayeb I, Henry P.
Successful treatment of hypnic headache syndrome with acetazolamide.
Neurology.
2003;
61
1157-1158
44
Silberstein S D, Niknam R, Rozen T D, Young W B.
Cluster headache with aura.
Neurology.
2000;
54
219-221
45
Sjaastad O, Dale I.
A new (?) Clinical headache entity „chronic paroxysmal hemicrania” 2.
Acta Neurol Scand.
1976;
54
140-159
46
Sjaastad O, Dale I.
Evidence for a new (?), treatable headache entity.
Headache.
1974;
14
105-108
47
Sjaastad O, Saunte C, Salvesen R. et al .
Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea.
Cephalalgia.
1989;
9
147-156
48
Sjaastad O, Spierings E L.
„Hemicrania continua”: another headache absolutely responsive to indomethacin.
Cephalalgia.
1984;
4
65-70
49
Soyka D, Spitzer M.
Die internationale Klassifikation von Kopfschmerzerkrankungen. 2. Auflage.
Nervenheilkunde.
2003;
22
531-670
50
Spierings E L.
Episodic and chronic paroxysmal hemicrania.
Clin J Pain.
1992;
8
44-48
51
van Vliet J A, Bahra A, Martin V. et al .
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
Neurology.
2003;
60
630-633
Dr. med. Jens Kuhn
Neurologische Klinik, Kliniken der Stadt Köln, Krankenhaus Merheim
Ostmerheimer Straße 200
51109 Köln
Telefon: +49/221/89073775
Fax: +49/221/89073772
eMail: JKuhn11@aol.com